TELO · Company research
Telomir Pharmaceuticals, Inc. Common Stock (TELO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| TELO GENOMICS CORP (TELO.NE) interactive stock chart - Yahoo Finance UK | TELO GENOMICS CORP (TELO.NE) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 17, 2026 | neutral | 0 | 0.6 |
| TELO GENOMICS CORP (TELO.NE) stock price, news, quote and history - Yahoo Finance UK | TELO GENOMICS CORP (TELO.NE) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 17, 2026 | neutral | 0 | 0.6 |
| TELO.NE Interactive Stock Chart | TELO GENOMICS CORP Stock - Yahoo Finance | TELO.NE Interactive Stock Chart | TELO GENOMICS CORP Stock Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals (TELO) Edges Higher to $1.18 as Shares Hold Above Key Support - Box Spread - dars.gov.et | Telomir Pharmaceuticals (TELO) Edges Higher to $1.18 as Shares Hold Above Key Support - Box Spread dars.gov.et | View source ↗ | dars.gov.et | Oct 4, 2026 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals (TELO) Edges Higher to $1.18 as Shares Hold Above Key Support - MFI Divergence - https://www.dars.gov.et/ | Telomir Pharmaceuticals (TELO) Edges Higher to $1.18 as Shares Hold Above Key Support - MFI Divergence https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 4, 2026 | neutral | 0 | 0.6 |
| A blood test found myeloma cells in all 10 follow-up samples; marrow tests called four negative. - Stock Titan | A blood test found myeloma cells in all 10 follow-up samples; marrow tests called four negative. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Vision gains in fish study link Telomir (NASDAQ: TELO) eye data to its cancer program - Stock Titan | Vision gains in fish study link Telomir (NASDAQ: TELO) eye data to its cancer program Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
| Telomir (TELO) investors approve all 2026 votes - Stock Titan | Telomir (TELO) investors approve all 2026 votes Stock Titan | View source ↗ | Stock Titan | Sep 16, 2026 | neutral | 0 | 0.6 |
| A blood test detected myeloma cells in 92.9% of matched samples, versus 54.8% for bone-marrow testing. - Stock Titan | A blood test detected myeloma cells in 92.9% of matched samples, versus 54.8% for bone-marrow testing. Stock Titan | View source ↗ | Stock Titan | Sep 15, 2026 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals (TELO) Gains 3.81% to $1.09, Pressing Against Key Resistance at $1.14 - Ichimoku TK Cross - dars.gov.et | Telomir Pharmaceuticals (TELO) Gains 3.81% to $1.09, Pressing Against Key Resistance at $1.14 - Ichimoku TK Cross dars.gov.et | View source ↗ | dars.gov.et | Aug 14, 2026 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals (TELO) Gains 3.81% to $1.09, Pressing Against Key Resistance at $1.14 - Option Strike Build - https://www.siam.in/ | Telomir Pharmaceuticals (TELO) Gains 3.81% to $1.09, Pressing Against Key Resistance at $1.14 - Option Strike Build https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Aug 14, 2026 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals (TELO) awards director 50,000 options at $1.34 exercise price - Stock Titan | Telomir Pharmaceuticals (TELO) awards director 50,000 options at $1.34 exercise price Stock Titan | View source ↗ | Stock Titan | Jul 27, 2026 | neutral | 0 | 0.6 |
| Sen. Telo Taitague - guampdn.com | Sen. Telo Taitague guampdn.com | View source ↗ | guampdn.com | Jun 28, 2026 | neutral | 0 | 0.6 |
| TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death - Stocktwits | TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death Stocktwits | View source ↗ | Stocktwits | Nov 21, 2025 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for Telomir Pharmaceuticals, Inc. (TELO) - Zacks Investment Research | What is the current Price Target and Forecast for Telomir Pharmaceuticals, Inc. (TELO) Zacks Investment Research | View source ↗ | Zacks Investment Research | Jul 19, 2024 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals, Inc. (TELO) Stock Price, News, Quote & History - Yahoo! Finance Canada | Telomir Pharmaceuticals, Inc. (TELO) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Mar 21, 2024 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 10, 2024 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals, Inc. (TELO) stock price, news, quote and history - Yahoo Finance UK | Telomir Pharmaceuticals, Inc. (TELO) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Feb 10, 2024 | neutral | 0 | 0.6 |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) Historical Quotes - Nasdaq | Telomir Pharmaceuticals, Inc. Common Stock (TELO) Historical Quotes Nasdaq | View source ↗ | Nasdaq | Jan 19, 2024 | neutral | 0 | 0.6 |
| TELO: Telomir Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | TELO: Telomir Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Apr 15, 2019 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.